Related Experiment Video
Updated: Oct 15, 2025
09:01
Cancer-Associated Fibroblasts from Mouse Mammary Tumors as Tools for Molecular and Computational Studies
Published on: July 3, 2025
370
CSF2-STAT5 Signaling in TAMs Contributes to CSF1R Inhibition Resistance
Cancer Discovery
|October 30, 2021
Abstract:
CSF1R inhibition combined with STAT5 blockade normalized TAM phenotype and sustained tumor control.
Insights
Targeting CSF1R and STAT5 normalized tumor-associated macrophages (TAMs) and improved tumor control. This dual blockade offers a promising strategy for cancer therapy.
Area of Science:
- Immunology
- Oncology
- Molecular Biology
Background:
- Tumor-associated macrophages (TAMs) often promote tumor growth and immune suppression.
- CSF1R signaling is crucial for TAM recruitment and function.
- STAT5 signaling plays a role in TAM polarization and immunosuppression.
Purpose of the Study:
- To investigate the combined effects of CSF1R inhibition and STAT5 blockade on TAM phenotype.
- To evaluate the impact of this combined blockade on tumor control.
Main Methods:
- Pharmacological inhibition of CSF1R.
- Genetic or pharmacological blockade of STAT5.
- Flow cytometry to analyze TAM phenotype.
- Tumor growth assays to assess tumor control.
Main Results:
- Combined CSF1R inhibition and STAT5 blockade effectively normalized TAM phenotype.
- This dual blockade led to sustained tumor control in preclinical models.
Conclusions:
- Simultaneous targeting of CSF1R and STAT5 pathways can reprogram TAMs towards an anti-tumorigenic state.
- This combination therapy represents a potential therapeutic strategy for enhancing cancer treatment efficacy.
